Marina Babic
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Marina Babic has a total of 44 co-authors. Here are the top co-authors by number of shared publications:
- Chiara Romagnani
Charité – Universitaetsmedizin Berlin, corporate member of Freie Universitaet Berlin and Humboldt-Universitaet zu Berlin, Institute of Medical Immunology and Cluster of Excellence ImmunoPreCept, Berlin, Germany
3 shared publications - Astrid Krmpotić
Department of Histology and Embryology, Faculty of Medicine, University of Rijeka, Rijeka, Croatia
2 shared publications - Stipan Jonjic
Faculty of Medicine, University of Rijeka, 51000 Rijeka, Croatia
2 shared publications - Vanda Juranić Lisnić
Centre for Proteomics, Faculty of Medicine, University of Rijeka, Braće Branchetta 20, 51000 Rijeka, Croatia
2 shared publications - Adriana Tomic
Bioinformatics Program, Faculty of Computing & Data Sciences, Boston University, Boston, MA, USA
1 shared publication - Alec James Redwood
Institute for Immunology and Infectious Diseases, Murdoch University, Murdoch, Australia
1 shared publication
Latest Publications
- 7 April 2022
- Published by Springer Nature in Zeitschrift für Rheumatologie
- Vol. 81 (8) , 628-634
Rolle von angeborenen Rezeptoren bei chronischen Entzündungen und Autoimmunität
Zusammenfassung Die Aufklärung der Grundlagen chronischer Krankheitsverläufe und die Entwicklung geeigneter Behandlungsmethoden von Entzündungskrankheiten sind in der Biomedizin noch immer eine große Herausforderung. Die Mechanismen, die fehlgeleitete Immunreaktionen auslösen, sind größtenteils noch unbekannt. Von besonderem Interesse ist die Identifizierung von Kontrollpunkten oder Checkpoints, welche die Funktion und Differenzierung entzündungsfördernder Zellen während der Pathogenese regulieren, sowie von Methoden zur Modulation spezifischer Checkpoints als therapeutischen Ansatz. Angeborene Rezeptoren wie die Mitglieder der Natural-Killer-Group-2-Familie (NKG2X), natürliche Zytotoxizitätsrezeptoren (NCR) oder Toll-like-Rezeptoren (TLR) spielen eine wichtige Rolle bei der Modulation der Immunantwort. NKG2, Mitglied D (NKG2D) ist ein potenter Aktivierungsrezeptor des Immunsystems, der als Wächter für zelluläre Gefahrensignale bekannt ist, die von Zellen ausgehen, die einem Stress des endoplasmatischen Retikulums (ER), dem Zelltod oder einem entzündlichen Zytokinmilieu ausgesetzt sind. NKG2A/C binden das nichtklassische HLA-Klasse-I-Molekül, erkennen Veränderungen in der Ligandenexpression, die mit Transformation und Tumorzellstress einhergehen, und ihre Hauptfunktion besteht darin, hemmende bzw. aktivierende Signale an NK- und T‑Zellen zu senden. In dieser Übersichtsarbeit werden neue Erkenntnisse zum Verständnis der Rolle angeborener Rezeptoren bei chronischen Entzündungen und Autoimmunität mit besonderem Schwerpunkt auf dem Gefahrensensor-Rezeptor NKG2D und NKG2A/C präsentiert.
- 7 April 2022
- Published by Springer Nature in Zeitschrift für Rheumatologie
- Vol. 81 (8) , 628-634
Rolle von angeborenen Rezeptoren bei chronischen Entzündungen und Autoimmunität
Zusammenfassung Die Aufklärung der Grundlagen chronischer Krankheitsverläufe und die Entwicklung geeigneter Behandlungsmethoden von Entzündungskrankheiten sind in der Biomedizin noch immer eine große Herausforderung. Die Mechanismen, die fehlgeleitete Immunreaktionen auslösen, sind größtenteils noch unbekannt. Von besonderem Interesse ist die Identifizierung von Kontrollpunkten oder Checkpoints, welche die Funktion und Differenzierung entzündungsfördernder Zellen während der Pathogenese regulieren, sowie von Methoden zur Modulation spezifischer Checkpoints als therapeutischen Ansatz. Angeborene Rezeptoren wie die Mitglieder der Natural-Killer-Group-2-Familie (NKG2X), natürliche Zytotoxizitätsrezeptoren (NCR) oder Toll-like-Rezeptoren (TLR) spielen eine wichtige Rolle bei der Modulation der Immunantwort. NKG2, Mitglied D (NKG2D) ist ein potenter Aktivierungsrezeptor des Immunsystems, der als Wächter für zelluläre Gefahrensignale bekannt ist, die von Zellen ausgehen, die einem Stress des endoplasmatischen Retikulums (ER), dem Zelltod oder einem entzündlichen Zytokinmilieu ausgesetzt sind. NKG2A/C binden das nichtklassische HLA-Klasse-I-Molekül, erkennen Veränderungen in der Ligandenexpression, die mit Transformation und Tumorzellstress einhergehen, und ihre Hauptfunktion besteht darin, hemmende bzw. aktivierende Signale an NK- und T‑Zellen zu senden. In dieser Übersichtsarbeit werden neue Erkenntnisse zum Verständnis der Rolle angeborener Rezeptoren bei chronischen Entzündungen und Autoimmunität mit besonderem Schwerpunkt auf dem Gefahrensensor-Rezeptor NKG2D und NKG2A/C präsentiert.
- Open Access
- 3 August 2020
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 217 (8)
NK cell receptor NKG2D enforces proinflammatory features and pathogenicity of Th1 and Th17 cells
NKG2D is a danger sensor expressed on different subsets of innate and adaptive lymphocytes. Despite its established role as a potent activator of the immune system, NKG2D-driven regulation of CD4+ T helper (Th) cell–mediated immunity remains unclear. In this study, we demonstrate that NKG2D modulates Th1 and proinflammatory T-bet+ Th17 cell effector functions in vitro and in vivo. In particular, NKG2D promotes higher production of proinflammatory cytokines by Th1 and T-bet+ Th17 cells and reinforces their transcription of type 1 signature genes, including Tbx21. Conditional deletion of NKG2D in T cells impairs the ability of antigen-specific CD4+ T cells to promote inflammation in vivo during antigen-induced arthritis and experimental autoimmune encephalomyelitis, indicating that NKG2D is an important target for the amelioration of Th1- and Th17-mediated chronic inflammatory diseases.
- 3 August 2020
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 217 (8)
Open AccessNK cell receptor NKG2D enforces proinflammatory features and pathogenicity of Th1 and Th17 cells
NKG2D is a danger sensor expressed on different subsets of innate and adaptive lymphocytes. Despite its established role as a potent activator of the immune system, NKG2D-driven regulation of CD4+ T helper (Th) cell–mediated immunity remains unclear. In this study, we demonstrate that NKG2D modulates Th1 and proinflammatory T-bet+ Th17 cell effector functions in vitro and in vivo. In particular, NKG2D promotes higher production of proinflammatory cytokines by Th1 and T-bet+ Th17 cells and reinforces their transcription of type 1 signature genes, including Tbx21. Conditional deletion of NKG2D in T cells impairs the ability of antigen-specific CD4+ T cells to promote inflammation in vivo during antigen-induced arthritis and experimental autoimmune encephalomyelitis, indicating that NKG2D is an important target for the amelioration of Th1- and Th17-mediated chronic inflammatory diseases.
- Open Access
- 29 May 2019
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 216 (8) , 1809-1827
The complex of MCMV proteins and MHC class I evades NK cell control and drives the evolution of virus-specific activating Ly49 receptors
CMVs efficiently target MHC I molecules to avoid recognition by cytotoxic T cells. However, the lack of MHC I on the cell surface renders the infected cell susceptible to NK cell killing upon missing self recognition. To counter this, mouse CMV (MCMV) rescues some MHC I molecules to engage inhibitory Ly49 receptors. Here we identify a new viral protein, MATp1, that is essential for MHC I surface rescue. Rescued altered-self MHC I molecules show increased affinity to inhibitory Ly49 receptors, resulting in inhibition of NK cells despite substantially reduced MHC I surface levels. This enables the virus to evade recognition by licensed NK cells. During evolution, this novel viral immune evasion mechanism could have prompted the development of activating NK cell receptors that are specific for MATp1-modified altered-self MHC I molecules. Our study solves a long-standing conundrum of how MCMV avoids recognition by NK cells, unravels a fundamental new viral immune evasion mechanism, and demonstrates how this forced the evolution of virus-specific activating MHC I–restricted Ly49 receptors.
- 29 May 2019
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 216 (8) , 1809-1827
Open AccessThe complex of MCMV proteins and MHC class I evades NK cell control and drives the evolution of virus-specific activating Ly49 receptors
CMVs efficiently target MHC I molecules to avoid recognition by cytotoxic T cells. However, the lack of MHC I on the cell surface renders the infected cell susceptible to NK cell killing upon missing self recognition. To counter this, mouse CMV (MCMV) rescues some MHC I molecules to engage inhibitory Ly49 receptors. Here we identify a new viral protein, MATp1, that is essential for MHC I surface rescue. Rescued altered-self MHC I molecules show increased affinity to inhibitory Ly49 receptors, resulting in inhibition of NK cells despite substantially reduced MHC I surface levels. This enables the virus to evade recognition by licensed NK cells. During evolution, this novel viral immune evasion mechanism could have prompted the development of activating NK cell receptors that are specific for MATp1-modified altered-self MHC I molecules. Our study solves a long-standing conundrum of how MCMV avoids recognition by NK cells, unravels a fundamental new viral immune evasion mechanism, and demonstrates how this forced the evolution of virus-specific activating MHC I–restricted Ly49 receptors.
- Open Access
- 30 May 2018
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 9, 1219
The Role of Natural Killer Group 2, Member D in Chronic Inflammation and Autoimmunity
Current medicine and medical science puts great effort into elucidating the basis of chronicity and finding appropriate treatments for inflammatory diseases, however, the mechanisms driving aberrant immune responses are mostly unknown and deserve further study. Of particular interest is the identification of checkpoints which regulate the function and differentiation of pro-inflammatory cells during pathogenesis, along with means of their modulation for therapeutic purposes. Natural Killer Group 2, Member D (NKG2D) is a potent activator of the immune system, known as a sensor for “induced-self” ligands, i.e. cellular danger signals that, in the context of chronic inflammation and autoimmunity, can be presented by cells being exposed to an inflammatory cytokine milieu, endoplasmic reticulum stress or cell death. Engagement by such ligands can be translated by NKG2D into activation or co-stimulation of NK cells and different subsets of T cells, respectively, thus contributing to the regulation of the inflammatory response. In this review, we discuss the current knowledge on the contribution of the NKG2D-NKG2DL signaling axis during intestinal inflammation, type 1 diabetes, multiple sclerosis and rheumatoid arthritis, where the role of NKG2D has been associated either by aberrant expression of the receptor and its ligands and/or by functional data in corresponding mouse models.
- 30 May 2018
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 9, 1219
Open AccessThe Role of Natural Killer Group 2, Member D in Chronic Inflammation and Autoimmunity
Current medicine and medical science puts great effort into elucidating the basis of chronicity and finding appropriate treatments for inflammatory diseases, however, the mechanisms driving aberrant immune responses are mostly unknown and deserve further study. Of particular interest is the identification of checkpoints which regulate the function and differentiation of pro-inflammatory cells during pathogenesis, along with means of their modulation for therapeutic purposes. Natural Killer Group 2, Member D (NKG2D) is a potent activator of the immune system, known as a sensor for “induced-self” ligands, i.e. cellular danger signals that, in the context of chronic inflammation and autoimmunity, can be presented by cells being exposed to an inflammatory cytokine milieu, endoplasmic reticulum stress or cell death. Engagement by such ligands can be translated by NKG2D into activation or co-stimulation of NK cells and different subsets of T cells, respectively, thus contributing to the regulation of the inflammatory response. In this review, we discuss the current knowledge on the contribution of the NKG2D-NKG2DL signaling axis during intestinal inflammation, type 1 diabetes, multiple sclerosis and rheumatoid arthritis, where the role of NKG2D has been associated either by aberrant expression of the receptor and its ligands and/or by functional data in corresponding mouse models.
- Open Access
- 8 August 2016
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 213 (9) , 1835-1850
Inflammatory monocytes and NK cells play a crucial role in DNAM-1–dependent control of cytomegalovirus infection
The poliovirus receptor (PVR) is a ubiquitously expressed glycoprotein involved in cellular adhesion and immune response. It engages the activating receptor DNAX accessory molecule (DNAM)-1, the inhibitory receptor TIGIT, and the CD96 receptor with both activating and inhibitory functions. Human cytomegalovirus (HCMV) down-regulates PVR expression, but the significance of this viral function in vivo remains unknown. Here, we demonstrate that mouse CMV (MCMV) also down-regulates the surface PVR. The m20.1 protein of MCMV retains PVR in the endoplasmic reticulum and promotes its degradation. A MCMV mutant lacking the PVR inhibitor was attenuated in normal mice but not in mice lacking DNAM-1. This attenuation was partially reversed by NK cell depletion, whereas the simultaneous depletion of mononuclear phagocytes abolished the virus control. This effect was associated with the increased expression of DNAM-1, whereas TIGIT and CD96 were absent on these cells. An increased level of proinflammatory cytokines in sera of mice infected with the virus lacking the m20.1 and an increased production of iNOS by inflammatory monocytes was observed. Blocking of CCL2 or the inhibition of iNOS significantly increased titer of the virus lacking m20.1. In this study, we have demonstrated that inflammatory monocytes, together with NK cells, are essential in the early control of CMV through the DNAM-1–PVR pathway.
- 8 August 2016
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 213 (9) , 1835-1850
Open AccessInflammatory monocytes and NK cells play a crucial role in DNAM-1–dependent control of cytomegalovirus infection
The poliovirus receptor (PVR) is a ubiquitously expressed glycoprotein involved in cellular adhesion and immune response. It engages the activating receptor DNAX accessory molecule (DNAM)-1, the inhibitory receptor TIGIT, and the CD96 receptor with both activating and inhibitory functions. Human cytomegalovirus (HCMV) down-regulates PVR expression, but the significance of this viral function in vivo remains unknown. Here, we demonstrate that mouse CMV (MCMV) also down-regulates the surface PVR. The m20.1 protein of MCMV retains PVR in the endoplasmic reticulum and promotes its degradation. A MCMV mutant lacking the PVR inhibitor was attenuated in normal mice but not in mice lacking DNAM-1. This attenuation was partially reversed by NK cell depletion, whereas the simultaneous depletion of mononuclear phagocytes abolished the virus control. This effect was associated with the increased expression of DNAM-1, whereas TIGIT and CD96 were absent on these cells. An increased level of proinflammatory cytokines in sera of mice infected with the virus lacking the m20.1 and an increased production of iNOS by inflammatory monocytes was observed. Blocking of CCL2 or the inhibition of iNOS significantly increased titer of the virus lacking m20.1. In this study, we have demonstrated that inflammatory monocytes, together with NK cells, are essential in the early control of CMV through the DNAM-1–PVR pathway.